1. Home
  2. BYSI vs HHS Comparison

BYSI vs HHS Comparison

Compare BYSI & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

BUY

Current Price

$0.53

Market Cap

31.4M

Sector

Health Care

ML Signal

BUY

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

HOLD

Current Price

$4.19

Market Cap

34.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYSI
HHS
Founded
2010
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
34.0M
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
BYSI
HHS
Price
$0.53
$4.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 279.0K
31.4K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 97.35
EPS
★ N/A
N/A
Revenue
N/A
★ $159,570,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$49.96
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.53
$2.00
52 Week High
$2.44
$4.67

Technical Indicators

Market Signals
Indicator
BYSI
HHS
Relative Strength Index (RSI) 35.81 51.77
Support Level N/A $4.14
Resistance Level $0.80 $4.40
Average True Range (ATR) 0.08 0.09
MACD -0.02 -0.06
Stochastic Oscillator 3.10 27.37

Price Performance

Historical Comparison
BYSI
HHS

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: